Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now adds sections that guide users (How to Read a Study Record, Common Questions, How to Join a Study) and explicitly states that recruitment has ended; it also updates the Revision line from v3.5.5 to v3.6.0 and adjusts the Intervention/Treatment heading formatting.
    Difference
    0.4%
    Check dated 2026-06-15T08:22:39.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor platform or content-management update. The underlying study information and visible content remain unchanged.
    Difference
    0.0%
    Check dated 2026-06-08T04:23:04.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - The page's revision label has been updated from v3.5.3 to v3.5.4. - This signals a minor site version update that affects rendering but not the study data.
    Difference
    0.0%
    Check dated 2026-05-17T10:01:16.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a new site revision number, moving from v3.5.2 to v3.5.3. This represents an update to the ClinicalTrials.gov page software version rather than any change to the clinical trial details.
    Difference
    0.0%
    Check dated 2026-04-25T18:40:33.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. This appears to be a minor version bump with no changes to study content or interactions.
    Difference
    0.0%
    Check dated 2026-04-18T13:37:03.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:06:06.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.